1+ day, 16+ hour ago  (377+ words) Cross Bridge Bio develops a dual-payload ADC technology created by Kyoji Tsuchikama at the University of Texas Health Science Center. Eli Lilly and Company has agreed to acquire all outstanding shares of Cross Bridge Bio for up to $300m in cash,…...

1+ day, 10+ hour ago  (276+ words) Amazon has already collaborated with Memorial Sloan Kettering Cancer Center with its AI software. Amazon Web Services (AWS) is launching an artificial intelligence (AI) application to design and test novel drugs more quickly and confidently. The system, called Amazon Bio…...

1+ day, 14+ hour ago  (393+ words) The pharma giant's CEO, Joaquin Duato, forecasts strong growth acceleration for 2026, driven in part by psoriasis pill, Icotyde. As companies across the life sciences space gear up to debut their Q1 earnings, Johnson & Johnson (J&J) has kicked off proceedings by posting…...

1+ day, 15+ hour ago  (332+ words) Adcendo, a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for cancer treatment, has raised $75m in a Series C funding round. The financing will support Adcendo's ongoing advancement of its first-in-class and best-in-class ADC pipeline targeting cancers of high unmet medical…...

2+ day, 15+ hour ago  (436+ words) This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per Global Data. Novo Nordisk has partnered with tech giant Open AI to expedite its drug development efforts, as the Danish pharma looks…...

2+ day, 14+ hour ago  (664+ words) An analyst noted that this uptick may be a case of "frontloading, meaning the EU's 2026 export growth outlook may not be as strong. New figures debuted by the European Union (EU) have uncovered a significant rise in the year-on-year value…...

2+ day, 11+ hour ago  (483+ words) Annabel Kartal-Allen is a reporter for Clinical Trials Arena, Pharmaceutical Technology and Medical Device Network based in London, UK. Annabel holds interests in oncology, neurology and metabolic diseases. She has previous experience reporting for both the pharmaceutical and nutraceutical industries,…...

2+ week, 3+ day ago  (700+ words) In Association with Piramal Pharma Solutions Payload linkers play a vital role in antibody-drug conjugates (ADCs). They are the pharmacologically active component of the ADC, and their stability, safety and efficacy are major determinants in successful ADC design. As ADC…...

3+ day, 19+ hour ago  (228+ words) Regeneron will initially provide Telix with an upfront cash payment of $40m for access to the latter's radiopharmaceutical manufacturing platform for four therapeutic initiatives. There is an option for Regeneron to expand to another four programmes, which would involve further upfront…...

6+ day, 8+ hour ago  (312+ words) Bristol Myers Squibb (BMS) and Oxford Bio Therapeutics (OBT) have forged an alliance to discover and develop new T-cell engager (TCE) therapies for solid tumours " building on the latter company's partnership-heavy growth strategy. This agreement will see BMS pay an…...